Status:
COMPLETED
Predicting Treatment Outcomes With Intensive Outpatient Treatment for PTSD
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
The Robert W. Woodruff Foundation
Conditions:
Posttraumatic Stress Disorder
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The open-label clinical study explores potential modifiable predictors of treatment outcomes in a sample of 55 military service members and veterans with clinically significant PTSD symptoms who recei...
Detailed Description
Intensive Outpatient Prolonged Exposure (IOP-PE) is a three-week, intensive, individualized program that combines massed Prolonged Exposure with military-relevant treatment augmentations to treat post...
Eligibility Criteria
Inclusion
- Active duty military service members or veterans (18 years or older) who were impacted by Hurricane Harvey.
- Significant PTSD symptoms as measured by a Posttraumatic Stress Disorder Checklist (PCL-5) score of 34 or higher.
- Able to speak and read English (due to standardization of outcome measures)
- Able to participate in a three-week intensive outpatient program
Exclusion
- Current manic episode or psychotic symptoms requiring immediate stabilization or hospitalization (as determined by the bipolar and psychosis modules of the Mini International Neuropsychiatric Interview (MINI) and clinical judgment)
- Current and severe alcohol use warranting immediate intervention based on clinical judgment.
- Evidence of a moderate or severe traumatic brain injury (as determined by the inability to comprehend the baseline screening questionnaires)
- Current suicidal ideation severe enough to warrant immediate attention (as determined by the Depressive Symptoms Index - Suicidality Subscale and the Self-Injurious Thoughts and Behaviors Interview short form) and corroborated by a clinical risk assessment by a credentialed provider.
- Other psychiatric disorders severe enough to warrant designation as the primary disorder as determined by clinician judgment
Key Trial Info
Start Date :
November 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04307498
Start Date
November 26 2019
End Date
January 1 2022
Last Update
March 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States, 78229